1 research outputs found
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was partially funded by Optimum Patient Care Global and AstraZeneca Ltd. No funding was received by OPRI for its contribution.Peer reviewedPostprin